$1.48
-0.07-4.52%
At Close: -
$1.48
00.00%
After Hours: Jul 19, 7:31 PM EDT
15 minutes delayed
Comments
Loading...
Milestone Pharmaceuticals
MISTNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Milestone Pharmaceuticals (NASDAQ:MIST) Stock, Analyst Ratings, Price Targets, Forecasts
Milestone Pharmaceuticals Inc has a consensus price target of $11.2 based on the ratings of 5 analysts. The high is $25 issued by HC Wainwright & Co. on July 1, 2024. The low is $4 issued by Jefferies on June 20, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 1, 2024, May 30, 2024, and May 16, 2024, respectively. With an average price target of $25 between HC Wainwright & Co., there's an implied 1589.19% upside for Milestone Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Piper Sandler
TD Cowen
Jefferies
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for Milestone Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 03/22/2024 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 03/05/2024 | Buy Now | 237.84% | Piper Sandler | Edward Tenthoff | $6 → $5 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 12/27/2023 | Buy Now | 508.11% | TD Cowen | — | $17 → $9 | Maintains | Outperform | Get Alert |
| 08/14/2023 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | 170.27% | Jefferies | Chris Howerton | $8 → $4 | Downgrade | Buy → Hold | Get Alert |
| 05/23/2023 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2023 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2023 | Buy Now | 778.38% | Oppenheimer | Leland Gershell | $16 → $13 | Maintains | Outperform | Get Alert |
| 03/30/2023 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | → $25 | Reiterates | → Buy | Get Alert |
| 11/14/2022 | Buy Now | 1589.19% | HC Wainwright & Co. | Patrick Trucchio | $20 → $25 | Maintains | Buy | Get Alert |
| 04/22/2022 | Buy Now | 575.68% | Piper Sandler | Edward Tenthoff | $8 → $10 | Upgrade | Neutral → Overweight | Get Alert |
FAQ
What is the target price for Milestone Pharmaceuticals (MIST) stock?
The latest price target for Milestone Pharmaceuticals (NASDAQ:MIST) was reported by HC Wainwright & Co. on July 1, 2024. The analyst firm set a price target for $25.00 expecting MIST to rise to within 12 months (a possible 1589.19% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Milestone Pharmaceuticals (MIST)?
The latest analyst rating for Milestone Pharmaceuticals (NASDAQ:MIST) was provided by HC Wainwright & Co., and Milestone Pharmaceuticals reiterated their buy rating.
When was the last upgrade for Milestone Pharmaceuticals (MIST)?
The last upgrade for Milestone Pharmaceuticals Inc happened on April 22, 2022 when Piper Sandler raised their price target to $10. Piper Sandler previously had a neutral for Milestone Pharmaceuticals Inc.
When was the last downgrade for Milestone Pharmaceuticals (MIST)?
The last downgrade for Milestone Pharmaceuticals Inc happened on June 20, 2023 when Jefferies changed their price target from $8 to $4 for Milestone Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Milestone Pharmaceuticals (MIST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Milestone Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Milestone Pharmaceuticals was filed on July 1, 2024 so you should expect the next rating to be made available sometime around July 1, 2025.
Is the Analyst Rating Milestone Pharmaceuticals (MIST) correct?
While ratings are subjective and will change, the latest Milestone Pharmaceuticals (MIST) rating was a reiterated with a price target of $25.00 to $25.00. The current price Milestone Pharmaceuticals (MIST) is trading at is $1.48, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.